The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler<sup>®</sup> in COPD Patients in the Daily Clinical Practice
The efficacy of the fix-dose salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease (COPD) was only shown for the original product. This investigator-initiated study aimed to prove the efficacy and safety of Salflumix Easyhaler<sup>®</sup>, a second-entry product (dry...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
MDPI AG
2022-11-01
|
| سلاسل: | Applied Sciences |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/2076-3417/12/23/12142 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|